LISA CHEN: Open Payments
NPI 1689397994 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 36 payments from 15 companies in 2025. Trend: 2023 $1,166 · 2024 $1,344 · 2025 $923
Food & beverage: $828Education: $95
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $257 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Amgen Inc. | 2 | $51 |
| Philips North America LLC | 2 | $36 |
| Stryker Corporation | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| GENZYME CORPORATION | 2 | $34 |
| Viatris Specialty LLC | 1 | $28 |
Products named: DUPIXENT, NUCALA, FASENRA, TRELEGY ELLIPTA, BREZTRI, Vest Therapy Und, FLOWTRIEVER, UPTRAVI.
Industry payments across CA — which companies pay providers there.
